High Frequency Spinal Cord Stimulation, HF10 Therapy
Nevro Corp. (NYSE: NVRO), a medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Senza spinal cord stimulation (SCS) system.
Additional Information on Superior Pain Relief
More Information on High Frequency Spinal Cord Stimulation, HF10 Therapy (PDF)